The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030, {predicts Roots Analysis}

 

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”

 

The report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals. In addition, the study features an in-depth analysis, highlighting the capabilities of a diverse set of industry stakeholders. Amongst other elements, the report features the following:

§  A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.

§  An insightful four-dimensional comparison of the radiopharmaceutical manufacturers.

§  Tabulated profiles of key industry players based in North America, Europe and Asia-Pacific (shortlisted based on the company size of the players).

§  An analysis of recent partnerships and collaborations inked in this domain since 2017.

§  A detailed discussion on the supply chain model of medical isotope Mo-99 (Tc-99m).

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Target Therapeutic Area

§  Cardiology

§  Neurology

§  Oncology

§  Thyroid

§  Others

  • Application Area

§  Diagnostic

§  Therapeutic

§  Type of Diagnostic Radiopharmaceuticals

§  PET

§  SPECT

§  Type of Therapeutic Radiopharmaceuticals

§  Alpha Emitters

§  Beta Emitters

§  Others

§  Purpose of Production

§  In-House

§  Outsourcing

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific and the Rest of the World 

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

§  J James Davis, Vice President Quality / R&D, Shertech Laboratories

§  Andreas Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical School

§  Jan Pruim, Professor of Medical Imaging / Nuclear Medicine Physician, University Medical Center of Groningen

§  Michael van Dam, Professor, Crump Institute for Molecular Imaging, Molecular & Medical Pharmacology

§  Anonymous, ITM Isotopen Technologien München

 

Key companies covered in the report

§  Advanced Accelerator Applications

§  Belgian Nuclear Research Center (SCK•CEN)

§  Cardinal Health

§  China Isotope & Radiation Corporation

§  Curium Pharma

§  DuChemBio

§  Eckert & Ziegler

§  Eczacibasi-Monrol

§  GE Healthcare

§  Jubilant DraxImage

§  Lantheus Medical Imaging

§  Nihon Medi-Physics

§  Nordion

§  PETNET Solutions

§  SinoTau Pharmaceuticals

§  SOFIE

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

 

Other Recent Offerings

1.     High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030

2.     Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

3.     China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030

4.     Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

Comments

Post a Comment

Popular posts from this blog

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

    The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “ Microbial Contract Biomanufacturing Market, 2020-2030 ” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various...
Read more

Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 by Roots Analysis

  Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some of the key...
Read more

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more